Eisai, Novartis deal

Eisai’s Eisai Inc. subsidiary and Novartis’ Novartis Pharmaceuticals Corp. affiliate partnered to co-promote the combination of their respective cancer drugs Lenvima lenvatinib and Afinitor everolim...